Is a complete GANX research report available?

No complete published report is available for Gain Therapeutics, Inc. (GANX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · USD

$1.19

+0.02 (+1.7%)· Recorded snapshot

Market cap	51.9M
Net income (ttm)	-20.1M
EPS (ttm)	-$0.51
Shares out	43.6M
Volume	378,101
Beta	0.19

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -20.1M
EPS (ttm): -$0.51
Market cap: 51.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001819411
Company name	Gain Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	36269B105
Earnings date	2026-11-11
Earnings time	bmo
Employees	21
Employees change	-4
Employees growth	-16%
Enterprise value	$39.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
IPO date	2021-03-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US36269B1052
Last 10-K release date	2026-03-26
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$51.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$1.19
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GANX
U.S. state	Maryland
Website	https://gaintherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001819411

Company name

Gain Therapeutics, Inc.

Country

United States

Country code

CUSIP number

36269B105

Earnings date

2026-11-11

Earnings time

bmo

Employees

Employees change

-4

Employees growth

-16%

Enterprise value

$39.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

IPO date

2021-03-18

Is primary listing

Yes

Is SPAC

ISIN number

US36269B1052

Last 10-K release date

2026-03-26

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$51.9M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$1.19

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GANX

U.S. state

Maryland

Website

https://gaintherapeutics.com

Metric	Value
Earnings yield	-42.79%
FCF / EV yield	-49.11%
FCF yield	-37.12%
P/B ratio	4.49x
Price / tangible book value	4.55x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-42.79%

FCF / EV yield

-49.11%

FCF yield

-37.12%

P/B ratio

4.49x

Price / tangible book value

4.55x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-957,441
ROA	-95.51%
ROA (5Y)	-57.16%
ROCE	-160.97%
ROE	-268.3%
ROE (5Y)	-127.09%
ROIC	-148.18%

Metric

Value

Profit per employee

$-957,441

ROA

-95.51%

ROA (5Y)

-57.16%

ROCE

-160.97%

ROE

-268.3%

ROE (5Y)

-127.09%

ROIC

-148.18%

Metric	Value
EPS growth quarters	2
EPS growth years	2
Net income growth quarters	1
Net income growth years	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$49,531
EBIT	$-19.3M
EBITDA	$-19.2M
EPS	$-0.51
FCF per share	$-0.43
Financing cash flow	$25.4M
Free cash flow	$-19M
Free cash flow minus SBC	$-20.8M
Gross profit	$-10M
Income taxes	$906,540
Net borrowing	$-100,843
Net cash flow	$6.4M
Net income	$-20.1M
Operating cash flow minus SBC	$-20.8M
Operating income	$-19.3M
Stock-based compensation	$1.8M

Metric

Value

Depreciation and amortization

$49,531

EBIT

$-19.3M

EBITDA

$-19.2M

EPS

$-0.51

FCF per share

$-0.43

Financing cash flow

$25.4M

Free cash flow

$-19M

Free cash flow minus SBC

$-20.8M

Gross profit

$-10M

Income taxes

$906,540

Net borrowing

$-100,843

Net cash flow

$6.4M

Net income

$-20.1M

Operating cash flow minus SBC

$-20.8M

Operating income

$-19.3M

Stock-based compensation

$1.8M

Metric	Value
Book value per share	$0.26
Debt / equity	0.05
Long-term assets	$452,191
Long-term liabilities	$696,043
Net cash (debt)	$12.5M
Net cash / market cap	24.43%
Net cash growth	107.44%
Net debt / equity	-1.1
Piotroski F-Score	3
Property, plant and equipment	$313,887
Shareholders' equity	$11.3M
Tangible book value	$11.2M
Tangible book value per share	$0.26
Total assets	$15.4M
Total cash	$13.1M
Total debt	$609,874
Total liabilities	$4.1M
WACC	5.26%

Metric

Value

Book value per share

$0.26

Debt / equity

0.05

Long-term assets

$452,191

Long-term liabilities

$696,043

Net cash (debt)

$12.5M

Net cash / market cap

24.43%

Net cash growth

107.44%

Net debt / equity

-1.1

Piotroski F-Score

Property, plant and equipment

$313,887

Shareholders' equity

$11.3M

Tangible book value

$11.2M

Tangible book value per share

$0.26

Total assets

$15.4M

Total cash

$13.1M

Total debt

$609,874

Total liabilities

$4.1M

WACC

5.26%

Metric	Value
Current assets	$15M
Current liabilities	$3.4M
Current ratio	4.36
Net working capital	$-1.3M
Quick ratio	4.11
Working capital	$11.5M

Metric

Value

Current assets

$15M

Current liabilities

$3.4M

Current ratio

4.36

Net working capital

$-1.3M

Quick ratio

4.11

Working capital

$11.5M

Metric	Value
Buyback yield / dilution	-39.34%
Dividend yield	0%
Shareholder yield	-39.34%

Metric

Value

Buyback yield / dilution

-39.34%

Dividend yield

Shareholder yield

-39.34%

Metric	Value
150-day SMA	$1.78
1D price change	1.71%
1M price change	-33.43%
1M total return	-33.43%
1W price change	-0.42%
1W total return	-0.42%
1Y price change	-39.23%
1Y return CAGR	-39.25%
1Y total return	-39.23%
20-day SMA	$1.42
200-day SMA	$1.87
3M price change	-36.29%
3M total return	-36.29%
3Y price change	-59%
3Y return CAGR	-25.7%
3Y total return	-59%
50-day SMA	$1.66
50-day SMA vs 200-day SMA	50under200
52-week high	$4.34
52-week high date	2025-12-11
52-week low	$1.14
52-week low date	2026-10-27
5Y price change	-83.07%
5Y return CAGR	-29.9%
5Y total return	-83.07%
6M price change	-39.23%
6M total return	-39.23%
All-time high	$17.93
All-time high date	2021-04-12
All-time low	$0.89
All-time low date	2024-08-13
Average true range (ATR)	$0.10
Average volume	625.3K
Beta (1Y)	2.58
Beta (2Y)	1.7
Beta (5Y)	0.19
Change from 52-week high	-72.58%
Change from 52-week low	4.39%
Change from all-time high	-93.39%
Change from all-time low	33.15%
Change from open	1.71%
Day's gap	0%
Dollar volume	$449,940
High price	$1.19
Low price	$1.16
Monthly RSI	39.3
Open price	$1.17
Position in 52-week range	100%
Premarket change	-0.06%
Premarket close	$1.17
Premarket price	$1.17
Premarket volume	930
Previous close	$1.17
Price vs 150-day SMA	-33.39%
Price vs 20-day SMA	-16.25%
Price vs 200-day SMA	-36.63%
Price vs 50-day SMA	-28.44%
Relative volume	0.6
Return from IPO open	-89.57%
Return from IPO price	-89.36%
RSI	29.32
Sharpe ratio	0.05
Sharpe ratio (3Y)	0.14
Sharpe ratio (5Y)	-0.01
Sortino ratio	0.13
Sortino ratio (3Y)	0.26
Sortino ratio (5Y)	0.05
Volume	378.1K
Weekly RSI	33.91
YTD price change	-63.2%
YTD total return	-63.2%

Metric

Value

150-day SMA

$1.78

1D price change

1.71%

1M price change

-33.43%

1M total return

-33.43%

1W price change

-0.42%

1W total return

-0.42%

1Y price change

-39.23%

1Y return CAGR

-39.25%

1Y total return

-39.23%

20-day SMA

$1.42

200-day SMA

$1.87

3M price change

-36.29%

3M total return

-36.29%

3Y price change

-59%

3Y return CAGR

-25.7%

3Y total return

-59%

50-day SMA

$1.66

50-day SMA vs 200-day SMA

50under200

52-week high

$4.34

52-week high date

2025-12-11

52-week low

$1.14

52-week low date

2026-10-27

5Y price change

-83.07%

5Y return CAGR

-29.9%

5Y total return

-83.07%

6M price change

-39.23%

6M total return

-39.23%

All-time high

$17.93

All-time high date

2021-04-12

All-time low

$0.89

All-time low date

2024-08-13

Average true range (ATR)

$0.10

Average volume

625.3K

Beta (1Y)

2.58

Beta (2Y)

1.7

Beta (5Y)

0.19

Change from 52-week high

-72.58%

Change from 52-week low

4.39%

Change from all-time high

-93.39%

Change from all-time low

33.15%

Change from open

1.71%

Day's gap

Dollar volume

$449,940

High price

$1.19

Low price

$1.16

Monthly RSI

39.3

Open price

$1.17

Position in 52-week range

100%

Premarket change

-0.06%

Premarket close

$1.17

Premarket price

$1.17

Premarket volume

930

Previous close

$1.17

Price vs 150-day SMA

-33.39%

Price vs 20-day SMA

-16.25%

Price vs 200-day SMA

-36.63%

Price vs 50-day SMA

-28.44%

Relative volume

0.6

Return from IPO open

-89.57%

Return from IPO price

-89.36%

RSI

29.32

Sharpe ratio

0.05

Sharpe ratio (3Y)

0.14

Sharpe ratio (5Y)

-0.01

Sortino ratio

0.13

Sortino ratio (3Y)

0.26

Sortino ratio (5Y)

0.05

Volume

378.1K

Weekly RSI

33.91

YTD price change

-63.2%

YTD total return

-63.2%

Metric	Value
Float	42.6M
Float percentage	97.69%
Shares change (QoQ)	1.54%
Shares change (YoY)	39.34%
Shares held by insiders	2.31%
Shares held by institutions	20.38%
Shares outstanding	43.6M
Short % of float	7.49%
Short % of shares	7.31%
Short ratio	7.3 days

Metric

Value

Float

42.6M

Float percentage

97.69%

Shares change (QoQ)

1.54%

Shares change (YoY)

39.34%

Shares held by insiders

2.31%

Shares held by institutions

20.38%

Shares outstanding

43.6M

Short % of float

7.49%

Short % of shares

7.31%

Short ratio

7.3 days

Gain Therapeutics, Inc. (GANX)

Price

Financial snapshot

Fair-value bridge

Latest news · GANX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GANX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GANX

Frequently asked questions